Novartis and Sarepta tap Dyno Therapeutics to use machine learning for gene therapy
Update: 2025-10-03
Description
�The drug companies Novartis and Sarepta Therapeutics are entering partnerships with Dyno Therapeutics.Dyno is the just-launched spin-off from the lab of Harvard geneticist George Church, and it� could earn more than $2 billion from the deals.Dyno will use machine learning to design custom adeno....
This item belongs to: audio/rivet360-audio-collection.
This item has files of the following types: Archive BitTorrent, Columbia Peaks, Item Tile, Metadata, PNG, Spectrogram, VBR MP3
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
